Epocrates, Inc. Newsletters

July 2004 - Issue No. 37


	This month's issue includes: Epocrates Lab – Coming Soon! Free Epocrates MedTools™ Now Available Epocrates Provides Patient Assistance Program Information Keep Your Clinical Information Current - AutoUpdate Today! Epocrates Advocate of the Month – Chris Tidwell, DO

What's new this month at Epocrates

We are excited to announce that next month, in response to your many requests, we will launch Epocrates Lab™, our newest mobile diagnostic reference. We’d like to acknowledge all the clinicians in our network who took the time to help us develop this product. We’d also like to thank you personally for your continued support as an Epocrates subscriber. Please read on to learn more…



	Epocrates Lab – Coming Soon! Epocrates Lab is a user-friendly mobile guide to hundreds of diagnostic tests, covering collection, interpretation and reimbursement. It’s designed to be integrated with the Epocrates Dx™ disease reference and Epocrates Rx® or Epocrates Rx Pro™ drug references, to save you time as you evaluate, diagnose and treat patients. Epocrates Lab provides up-to-date and concise information on: Hundreds of diagnostic tests and panels Interpretation (disease, drug and spurious causes) Follow-up Preparation Pricing and reimbursement Please click here to learn more about Epocrates Lab. BACK TO TOPICS >>




		Free Epocrates MedTools™ for Cardiology and Primary CareEpocrates recently partnered with sponsors to launch two new Epocrates MedTools™* for cardiologists and primary care physicians. Once downloaded from the Epocrates website, these free tools are accessible from the black medical bag tab in the upper right hand corner of your Epocrates mobile software. STATCholesterol for cardiologists is an educational tool that automates the Adult Treatment Panel III (“ATP III”) and Framingham risk calculations. It allows you to input specific patient data, calculate 10-year risk of CHD, and identify LDL-reduction goals. Click here to download STATCholesterol.Compendica Psychiatry for Primary Care Physicians is a reference based on DSM-IV criteria. Built for the generalist and specialist, it provides comprehensive diagnostic and therapeutic recommendations, published guidelines and literature on over 25 diagnoses. It also includes information on epidemiology, diagnosis and treatment. Click here to download Compendica Psychiatry. *Epocrates Medtools are currently not available for Pocket PC devices BACK TO TOPICS >>
				STATCholesterol

				Compendica Psychiatry




	Epocrates Provides Patient Assistance Program Information Patient assistance programs provide no cost prescription medications to eligible participants. Through a partnership with NeedyMeds.com, Epocrates now publishes an updated list of these valuable programs. NeedyMeds.com is an Internet-based information source of pharmaceutical-sponsored assistance programs. As an integrated part of the Epocrates drug guide, the NeedyMeds list will help you quickly determine whether a patient assistance program exists for a drug and includes a phone number and website for more information about each program. At the NeedyMeds.com website physicians or patients can look up eligibility criteria and instructions for each program and download application forms. To access the NeedyMeds list of drug programs on Epocrates, you must first add it your Epocrates formulary list. Visit our website at www.epocrates.com and click on Add Formularies. Select “NeedyMeds” listed under “Other Groups” in every state.

	Download the NeedyMeds program list		Tap on the “Y” codes for program details
	BACK TO TOPICS >>




	Keep Your Clinical Information Current - AutoUpdate Today! One of the most important ways Epocrates contributes to enhancing patient safety is by providing reliable and up-to-date drug and clinical reference information. The Epocrates Medical Information Editors are regularly adding new drugs and updating content in our clinical references including new indications, FDA Medwatch changes, new drug-drug interactions and more. Please keep in mind that the list below highlights only key changes made to the clinical references. To keep your information current and reduce the risk of inadvertent medication errors, we recommend you AutoUpdate your Epocrates mobile references at least once per week. New FDA-approved prescription drugs Ertaczo - topical antifungal for the treatment of tinea pedis in adults and children >12 yo Orthovisc - intraarticular injection for the treatment of adult osteoarthritis of the knee Spiriva Handihaler - inhaled anticholinergic bronchodilator for maintenance treatment of adult bronchospasm in COPD New monographs for previously approved prescription drugs amcinonide topical ammonium lactate topical econazole topical Hyalgan Synalgos-DC New Adult and Pediatric FDA approved indications for previously approved prescription drugs Aldara - adult actinic keratosis bacitracin topical - pediatric superficial infection Enbrel - adult moderate-severe plaque psoriasis Trusopt - pediatric elevated intraocular pressure Depakote ER - pediatric seizure disorder MedWatch labeling change-related edits to previously approved prescription drugs Accolate - serious reactions Aldara - contraindications, adverse effects, pregnancy category Cytotec - contraindications, serious reactions Desyrel - drug interactions Idamcyin - contraindications, adverse effects Inderide - precautions Midamor - precautions Myambutol - contraindications, serious reactions, drug interactions Status change for previously approved prescription drugs Dizac - brand discontinued Hygroton - brand discontinued Intropin - brand discontinued Ogen vaginal - brand discontinued Robaxisal - brand discontinued Serzone - brand discontinued Tridil - brand discontinued New Tables (Epocrates Rx Pro users only) Warfarin: Overanticoag. Mgmt - based on ACCP; Chest 2001 Alternative medicine monograph edits (Epocrates Rx Pro users only) black cohosh coenzyme Q-10 fish oils green tea guarana kava New Epocrates Dx Monographs Multiple endocrine neoplasia (MEN) Peritonsillar Abscess BACK TO TOPICS >>

-


	Epocrates Advocate of the Month – Chris Tidwell, DO Advocate of the Month This month, we have selected Chris Tidwell, a chief resident from Grandview Medical Center in Dayton, Ohio to be our Advocate of the Month. We would like to thank Dr. Tidwell for providing valuable product development feedback over the past several years and for educating his colleagues about Epocrates products. "I have been using Epocrates products since early 1999 and have seen firsthand the development of products from the company and their profound contribution and impact on the technological aspect of the medical world. One of the aspects that I have admired the most has been Epocrates’ innovation. They have continually been one step ahead of the demands and expectations from the medical community with such clinical references as Epocrates Rx® drug and formulary reference, Epocrates ID® infectious disease guide, Epocrates Rx Pro™ premium clinical reference, Epocrates Rx Online™ desktop drug reference, Epocrates Dx™ disease diagnosis and treatment reference and now Epocrates Lab™. Being an Emergency Medicine resident physician I need to be highly efficient with my time and energies. I am continually amazed by how helpful Epocrates software is to my everyday work and how they continue to create such tremendous products for the entire medical community. Epocrates products bring even more value to my medical arsenal. I recommend it to all my fellow students, residents and clinicians." -Chris Tidwell, DO Emergency Medicine Chief Resident (PGY-4) Grandview Medical Center, Dayton, OH Advocate Program We created the Advocate Program for users who are interested in sharing information about Epocrates software with colleagues. For example, many Advocates demonstrate Epocrates software at medical society conferences and academic grand rounds. For more information on the Epocrates Advocate Program including how to join, please visit our website. BACK TO TOPICS >>

----00


	If you do not want to receive future emails from Epocrates, which include clinical and formulary updates, product development news, our monthly newsletter and other important company information, please click here, login with your username and password, and modify your user profile. 1100 Park Place, Suite 300 San Mateo, CA 94403

This concludes the July issue of the Epocrates Newsletter.

If you are interested in reading past issues of the Epocrates newsletter that you might have missed, you can now find them posted to our website by clicking here.

Best wishes,

The Epocrates Team